|
| |
| | | 58219 | | 17.04.2008 | | Teva Pharma AG | | | | | | | | | | | | | 01.09. | | | | 01.09. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Ondansetron-Mepha 4 oro | Schmelztabletten | Melting tablets () | A04AA01 | CI | | 02 | Ondansetron-Mepha 8 oro | Schmelztabletten | Melting tablets () | A04AA01 | CI | | 03 | Ondansetron-Teva 4 oro | Schmelztabletten | Melting tablets (Ondansetron 4 mg) | A04AA01 | CI | | 04 | Ondansetron-Teva 8 oro | Schmelztabletten | Melting tablets (Ondansetron 8 mg) | A04AA01 | CI |
|
|
|
